Seed round raised from existing investors (True Ventures, BKR Capital, Centre for Aging and Brain Health Innovation, Health2047 and others) - $4.5M to date. Securing of MassAITC pilot funding helped in due diligence with investors for their seed round, and thus was critical to closing their funding including with Health2047, venture arm of the American Medical Association and with other early stage investors. Source: businesswire
"We are excited to partner with Moneta to make personalized, evidence-based cognitive rehabilitation the standard of care for our patients and families. Montana is vast and has the sixth oldest population in the nation. Moneta’s proven program is an accessible approach to proactive brain health for our aging demographic." Dr. Greg Tierney, President of System Clinical Operations at Benefis Health System. LAS VEGAS--(BUSINESS WIRE)--Moneta Health, a brain health company pioneering cognitive rehabilitation therapy through AI-powered delivery, today announced a $4.5 million funding round and a new partnership with Benefis Health System to expand access to cognitive care in neurology deserts. The company has signed a multi-year partnership with Benefis Health System in Montana and secured investment from venture capital firms including True Ventures and Health2047, the American Medical Association’s venture studio, to support its mission…
The MassAITC funded pilot project was the first to shift the use-case of the Rendever VR into the home setting. This grant furthers the push into the home by Rendever as a commercially viable solution to enable older adults aging at home to be more socially connected with their peers.This Commercial Readiness Pilot project builds on the success of their Phase I pilot study and Phase II STTR clinical trial by extending Rendever's virtual reality (VR) platform to enhance social connectivity among older adults who are aging in place, a majority of the aging population that Rendever is not yet serving. Older adults living at home will be connected with those living in senior living communities, where Rendever is already successfully implemented, through shared VR experiences. This project contributes to public health by testing the…
Project Narrative: The NIH STTR Phase I project aims to improve the Obi robotic feeding system with advanced technology, allowing it to autonomously deliver food to individuals with severe upper limb disabilities. This enhancement will provide a more independent eating experience, reduce caregiver burden, and has the potential to improve the quality of life for millions of people with mobility impairments. Source: 1R41AG092186-01A1 (NIH RePORTER)
Authors: Tzu-An Song, Yubo Zhang, Ziyuan Zhou, Luke Hou, Masoud Malekzadeh, Aida Behzad, Joyita Dutta Abstract Polysomnography, the gold standard for sleep evaluations, involves complex setup and data acquisition protocols and requires manual scoring of sleep data. Smartwatches and other multi-sensor consumer wearable devices with automated sleep staging capabilities offer a promising and scalable alternative for routine and long-term sleep evaluations in individuals. We conducted a multi-night study using a smartwatch for sleep assessment and created an AI-driven automated sleep staging framework based on instantaneous heart rate (IHR) and accelerometry data using sleep stage labels based on electroencephalography (EEG) as the reference. 47 healthy adults were recruited to record their sleep for up to seven consecutive nights using an Apple Watch Series 6 and a Dreem 2 Headband. Our sleep staging framework relies on a…
Abstract: This proposal responds to an acute challenge currently underserved by technology; the need to leverage novel approaches to develop cost-effective and responsive digital, mobile, website, and artificial intelligence (AI) tools to encourage participation in Alzheimer disease and related dementias (ADRD) clinical trials. With ADRD cases expected to double by 2060, efforts to ensure adequate participation in ADRD clinical trials is paramount to ensuring successful biomedical advances and drug development. Despite ongoing efforts to improve ADRD outcomes and clinical trial participation, no digital solution exists which has been purposefully designed and co-developed in partnership with patients at higher-risk of ADRD or with informal caregivers of ADRD patients critical in addressing challenges associated with trial participation. In response, this project utilizes approaches in digital tool development, AI, qualitative interviews and small group discussions, and use of…
Emerging Technology Category: The Emergency Technology category acknowledges innovators who have developed technology-driven tools showing great potential for improving care and/or the bottom line, even though they are not yet in the broad marketplace. Neursantys won top honors in this category for their pilot study with The Forum at Rancho San Antonio and LCS for their entry titled “NEURVESTA Vestibular Stimulation Therapy for Restoring Balance.” The study, involving 35 residents, showed that the protocol can enhance balance and lower the risk of falls, resulting in residents feeling more confident to participate in group outings and return to their exercise classes, and delaying the potential need for a higher level of care. Falls Prevention, Management or Detection: The Falls Prevention, Management or Detection category recognizes the use of technology that helps providers reduce the risk of…